Spasticity Management After Stroke

Physical Medicine and Rehabilitation Clinics of North America

Volumn 26, Issue 4, 2015, Pages 625-639

  Bethoux, Francois ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Outcome measures; Rehabilitation; Spasticity; Stroke; Symptom management

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CANNABIS DERIVATIVE; DANTROLENE; DIAZEPAM; GABAPENTIN; PHENOL; PREGABALIN; TIZANIDINE; MUSCLE RELAXANT AGENT;

AEROBIC EXERCISE; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DORSAL RHIZOTOMY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENDURANCE TRAINING; GAIT ORTHOSIS; HUMAN; HYPERTHERMIC THERAPY; META ANALYSIS (TOPIC); MUSCLE TRAINING; NERVE SURGERY; NEUROMUSCULAR ELECTRICAL STIMULATION; NEUROTOMY; ORTHOPEDIC CAST; ORTHOPEDIC SURGERY; PATIENT ASSESSMENT; PATIENT EDUCATION; PATIENT REFERRAL; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; REVIEW; ROBOTICS; SELECTIVE DORSAL RHIZOTOMY; SIDE EFFECT; SPASTICITY; SPLINT; STRETCHING; ULTRASOUND THERAPY; MUSCLE SPASTICITY; PATHOPHYSIOLOGY; STROKE;

HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; STROKE;

EID: 84946473029     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2015.07.003     Document Type: Review

References (49)

1. Lance J. Symposium synopsis. Spasticity: disordered motor control 1980, 485-494. Year Book Medical Publishers, Chicago. R.G. Feldman, R.R. Young, W.P. Koella (Eds.).
2. Lamy J.C., Wargon I., Mazevet D., et al. Impaired efficacy of spinal presynaptic mechanisms in spastic stroke patients. Brain 2009, 132:734-748.
3. Burke D., Wissel J., Donnan G.A. Pathophysiology of spasticity in stroke. Neurology 2013, 80(3 Suppl 2):S20-S26.
4. Dietz V., Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007, 6:725-733.
5. Wissel J., Schelosky L.D., Scott J., et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol 2010, 257(7):1067-1072.
6. Landau W.M. Spasticity after stroke: why bother?. Stroke 2004, 35:1787-1788.
7. National Stroke Association Stroke Perceptions Study, June 2006. Available at: , Accessed March 1, 2015. http://support.stroke.org/site/DocServer/StrokePerceptions_FinalSurveyResults_2006.pdf?docID=1941.
8. Wissel J., Manack A., Brainin M. Toward an epidemiology of poststroke spasticity. Neurology 2013, 80(3 Suppl 2):S13-S19.
9. Opheim A., Danielsson A., Alt Murphy M., et al. Upper limb spasticity during the first year after stroke: stroke arm longitudinal study at the University of Gothenburg. Am J Phys Med Rehabil 2014, 93:884-896.
10. Welmer A.K., Widén Holmqvist L., Sommerfeld D.K. Location and severity of spasticity in the first 1-2 weeks and at 3 and 18 months after stroke. Eur J Neurol 2010, 17(5):720-725.
11. Available at: . Accessed March 1, 2015. http://www.neuropt.org/docs/stroke-sig/strokeedge_taskforce:summary_document.pdf?sfvrsn=2.
12. Turner-Stokes L., Baguley I.J., De Graaff S., et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med 2010, 42(1):81-89.
13. Lundstrom E., Terent A., Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol 2008, 15:533-539.
14. VA/DoD Clinical Practice Guideline for the Management of Stroke Rehabilitation. Version 2.0. October 2010. Available at: . Accessed March 1, 2015. http://www.rehab.research.va.gov/jour/10/479/pdf/VADODcliniaclGuidlines479.pdf.
15. Bakheit A.M. The pharmacological management of post-stroke muscle spasticity. Drugs Aging 2012, 29(12):941-947.
16. Yelnik A.P., Simon O., Parratte B., et al. How to clinically assess and treat muscle overactivity in spastic paresis. J Rehabil Med 2010, 42(9):801-807.
17. Francisco G.E., McGuire J.R. Post-stroke spasticity management. Stroke 2012, 43:3132-3136.
18. Sunnerhagen K.S., Francisco G.E. Enhancing patient-provider communication for long-term post-stroke spasticity management. Acta Neurol Scand 2013, 128(5):305-310.
19. Santus G., Faletti S., Bordanzi I., et al. Effect of short-term electrical stimulation before and after botulinum toxin injection. J Rehabil Med 2011, 43(5):420-423.
20. Dundar U., Toktas H., Solak O., et al. A comparative study of conventional physiotherapy versus robotic training combined with physiotherapy in patients with stroke. Top Stroke Rehabil 2014, 21(6):453-461.
21. Zhang M., Davies T.C., Xie S. Effectiveness of robot-assisted therapy on ankle rehabilitation-a systematic review. J Neuroeng Rehabil 2013, 10:30.
22. Fazekas G., Horvath M., Troznai T., et al. Robot-mediated upper limb physiotherapy for patients with spastic hemiparesis: a preliminary study. J Rehabil Med 2007, 39(7):580-582.
23. Malfitano A.M., Proto M.C., Bifulco M. Cannabinoids in the management of spasticity associated with multiple sclerosis. Neuropsychiatr Dis Treat 2008, 4(5):847-853.
24. Kocabas H., Salli A., Demir A.H., et al. Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study. Eur J Phys Rehabil Med 2010, 46(1):5-10.
25. Simpson D.M., Gracies J.M., Graham H.K., et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70(19):1691-1698.
26. Foley N., Murie-Fernandez M., Speechley M., et al. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol 2010, 17(12):1419-1427.
27. Foley N., Pereira S., Salter K., et al. Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. Arch Phys Med Rehabil 2013, 94(5):977-989.
28. Francisco G.E., Yablon S.A., Schiess M.C., et al. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil 2006, 13(4):74-85.
29. Ivanhoe C.B., Francisco G.E., McGuire J.R., et al. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil 2006, 87:1509-1515.
30. Francisco G.E., Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehabil 2003, 84:1194-1199.
31. Schiess M.C., Oh I.J., Stimming E.F., et al. Prospective 12-month study of intrathecal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement. Neuromodulation 2011, 14:38-45.
32. Rousseaux M., Buisset N., Daveluy W., et al. Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity. Eur J Neurol 2008, 15:506-511.
33. Gump W.C., Mutchnick I.S., Moriarty T.M. Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria. Neurosurg Focus 2013, 35(5):E6.
34. Fukuhara T., Kamata I. Selective posterior rhizotomy for painful spasticity in the lower limbs of hemiplegic patients after stroke: report of two cases. Neurosurgery 2004, 54:1268-1273.
35. Demetrios M., Khan F., Turner-Stokes L., et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013, (6). CD009689.
36. Draulans N., Vermeersch K., Degraeuwe B., et al. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. Clin Rehabil 2013, 27(12):1137-1143.
37. Naumann M., Boo L.M., Ackerman A.H., et al. Immunogenicity of botulinum toxins. J Neural Transm 2013, 120(2):275-290.
38. Pandyan A.D., Johnson G.R., Price C.I.M., et al. A review of the properties and limitations of the Ashworth and Modified Ashworth Scales as measures of spasticity. Clin Rehabil 1999, 13:373-383.
39. Tardieu G., Shentoub S., Delarue R. A la recherche d'une technique de mesure de la spasticite. Rev Neurol 1954, 91:143-144.
40. Mehrholz J., Wagner K., Meißner D., et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clin Rehabil 2005, 19:751-759.
41. Li F., Wu Y., Xiong L. Reliability of a new scale for measurement of spasticity in stroke patients. J Rehabil Med 2014, 46(8):746-753.
42. Penn R.D., Savoy S.M., Corcos D., et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989, 320:1517-1521.
43. Snow B.J., Tsui J.K.C., Bhatt M.H., et al. Treatment of spasticity with botulinum toxin: a double blind study. Ann Neurol 1990, 28:512-515.
44. Farrar J.T., Troxel A.B., Stott C., et al. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008, 30(5):974-985.
45. Pisano F., Miscio G., Conte C.D., et al. Quantitative measures of spasticity in poststroke patients. Clin Neurophysiol 2000, 111:1015-1022.
46. Bohannon R.W., Harrison S., Kinsella-Shaw J. Reliability and validity of pendulum test measures of spasticity obtained with the Polhemus tracking system from patients with chronic stroke. J Neuroeng Rehabil 2009, 6:30.
47. Bakheit A.M., Maynard V.A., Curnow J., et al. The relation between Ashworth scale scores and the excitability of the alpha motor neurones in patients with post-stroke muscle spasticity. J Neurol Neurosurg Psychiatry 2003, 74:646-648.
48. Calota A., Levin M.F. Tonic stretch reflex threshold as a measure of spasticity: implications for clinical practice. Top Stroke Rehabil 2009, 16(3):177-188.
49. Ward A.B., Aquilar M., De Beyl Z., et al. Use of botulinum toxin type A in management of adult spasticity-a European consensus statement. J Rehabil Med 2003, 35:98-99.